US court grants CureVac's request to transfer Pfizer/BioNTech's COVID vaccine patent case
19/05/2023 12:18
May 19 (Reuters) - CureVac NV CVAC.O said on Friday its request to transfer the ongoing patent litigation filed by Pfizer Inc PFE.N and its German partner BioNTech BNTX.O to the Eastern District of Virginia from the federal district court of Massachusetts has been granted. (Reporting by Raghav Mahobe in Bengaluru) ((Raghav.Mahobe@thomsonreuters.com;))
Recent news on CureVac NV
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Biontech Closes Acquisition Of CureVac
Brief: BioNTech Says CureVac Shareholders Are Advised To Tender Their Shares By 6:00 P.M. Eastern Time On Tuesday, December 2, 2025
Brief: Curevac Reaffirms Its Expected Cash Runway Into 2028